Understanding cancer stem cells and plasticity: Towards better therapeutics

被引:14
作者
Warrier, Neerada Meenakshi [1 ]
Kelkar, Nachiket [1 ]
Johnson, Carol Tresa [1 ]
Govindarajan, Thirupugal [2 ]
Prabhu, Vijendra [1 ]
Kumar, Praveen [1 ]
机构
[1] Manipal Acad Higher Educ, Manipal Inst Technol, Dept Biotechnol, Manipal 576104, Karnataka, India
[2] Cincinnati Childrens Hosp Med Ctr, Cincinnati, OH USA
关键词
Transdifferentiation; Cell fusion; Metabolic reprogramming; Paligenosis; Epithelial-mesenchymal transition; Tumor microenvironment; EPITHELIAL-MESENCHYMAL TRANSITION; METASTATIC COLONIZATION; EPIGENETIC REGULATION; TUMOR HETEROGENEITY; PROMOTES METASTASIS; SELF-RENEWAL; TRANSDIFFERENTIATION; IDENTIFICATION; MECHANISMS; FUSION;
D O I
10.1016/j.ejcb.2023.151321
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
The ability of cancer cells to finally overcome various lines of treatment in due course has always baffled the scientific community. Even with the most promising therapies, relapse is ultimately seen, and this resilience has proved to be a major hurdle in the management of cancer. Accumulating evidence now attributes this resilience to plasticity. Plasticity is the ability of cells to change their properties and is substantial as it helps in normal tissue regeneration or post-injury repair processes. It also helps in the overall maintenance of homeostasis. Unfortunately, this critical ability of cells, when activated incorrectly, can lead to numerous diseases, including cancer. Therefore, in this review, we focus on the plasticity aspect with an emphasis on cancer stem cells (CSCs). We discuss the various forms of plasticity that provide survival advantages to CSCs. Moreover, we explore various factors that affect plasticity. Furthermore, we provide the therapeutic implications of plasticity. Finally, we provide an insight into the future targeted therapies involving plasticity for better clinical outcomes.
引用
收藏
页数:12
相关论文
共 130 条
  • [1] The Role of the IL-6 Cytokine Family in Epithelial-Mesenchymal Plasticity in Cancer Progression
    Abaurrea, Andrea
    Araujo, Angela M.
    Caffarel, Maria M.
    [J]. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2021, 22 (15)
  • [2] Stem-Like Ovarian Cancer Cells Can Serve as Tumor Vascular Progenitors
    Alvero, Ayesha B.
    Fu, Han-Hsuan
    Holmberg, Jennie
    Visintin, Irene
    Mor, Liora
    Marquina, Carlos Cano
    Oidtman, Jessica
    Silasi, Dan-Arin
    Mor, Gil
    [J]. STEM CELLS, 2009, 27 (10) : 2405 - 2413
  • [3] Andriani F., 2016, MOL ONCOL
  • [4] Atena M., 2014, STEM CELL DISCOV, V4, P83, DOI [10.4236/scd.2014.44009, DOI 10.4236/SCD.2014.44009]
  • [5] Epigenetic regulation of CD133 and tumorigenicity of CD133+ovarian cancer cells
    Baba, T.
    Convery, P. A.
    Matsumura, N.
    Whitaker, R. S.
    Kondoh, E.
    Perry, T.
    Huang, Z.
    Bentley, R. C.
    Mori, S.
    Fujii, S.
    Marks, J. R.
    Berchuck, A.
    Murphy, S. K.
    [J]. ONCOGENE, 2009, 28 (02) : 209 - 218
  • [6] Tumor microenvironment: Bone marrow-mesenchymal stem cells as key players
    Barcellos-de-Souza, Pedro
    Gori, Valentina
    Bambi, Franco
    Chiarugi, Paola
    [J]. BIOCHIMICA ET BIOPHYSICA ACTA-REVIEWS ON CANCER, 2013, 1836 (02): : 321 - 335
  • [7] Begum A., 2019, PANCREAS
  • [8] EMT-induced metabolite signature identifies poor clinical outcome
    Bhowmik, Salil Kumar
    Ramirez-Pena, Esmeralda
    Arnold, James Michael
    Putluri, Vasanta
    Sphyris, Nathalie
    Michailidis, George
    Putluri, Nagireddy
    Ambs, Stefan
    Sreekumar, Arun
    Mani, Sendurai A.
    [J]. ONCOTARGET, 2015, 6 (40) : 42651 - 42660
  • [9] Human acute myeloid leukemia is organized as a hierarchy that originates from a primitive hematopoietic cell
    Bonnet, D
    Dick, JE
    [J]. NATURE MEDICINE, 1997, 3 (07) : 730 - 737
  • [10] Targeting self-renewal pathways in cancer stem cells: clinical implications for cancer therapy
    Borah, A.
    Raveendran, S.
    Rochani, A.
    Maekawa, T.
    Kumar, D. S.
    [J]. ONCOGENESIS, 2015, 4 : e177 - e177